Clinical Supply Logistic Articles
-
Supplying Complex, Controversial, And Intercontinental Clinical Trials
3/13/2024
Planning a clinical supply strategy for a complicated substance, psilocybin, is tricky. It's even more tricky doing it from the other side of the planet. Here's one company's approach.
-
Do ClinOps Professionals Understand The CAR-T Supply Chain?
3/4/2024
Lee Clough RN, HP, of Novartis talks about the importance of understanding the nuances associated with collecting and shipping autologous material (i.e., CAR-Ts) for clinical trials.
-
The Impact Of Protocol Design On An IRT System
1/31/2024
DTP and home treatment studies can get expensive — and be a hassle to patients — if the IRT element isn’t well planned for during trial design. In their SCOPE Summit presentation, Irina Grishina and Kelsey Kern of CSL Behring plan to share their personal anecdotes and lessons learned from both types of trials as they pertain to IRT.
-
Donating Surplus Clinical Trial Supplies Is Sustainability's “Low-Hanging Fruit”
1/29/2024
ClinOps professionals know all too well the waste that occurs with leftover trial kits that are destroyed at the end of the trial. Explore donation as a way to give those kits a second life.
-
Cryo-Shippers: Challenges, Controls, And Logistics
1/3/2024
Cryo-shippers are essential for shipping advanced therapeutics, but how do you choose and validate the right one? This article from BMS experts offers insights.
-
Clinical Trial Supply Market Outlook, Developments, & Technology Trends
12/26/2023
The clinical trial supplies market is estimated at $3.9 billion in 2023 and is projected to reach $6.3 billion by 2028. Explore more insights from Markets and Markets.
-
Bayesian Adaptive Designs in Clinical Trials: Using Data Science To Optimize Investigational Product Supply
11/30/2023
While it is challenging to make precise predictions for clinical trial supplies, applying Bayesian statistics will help. This article shares steps to plan your Bayesian approach and how it helps to reduce waste and prevent shortages.
-
Outsourcing And Phase-Appropriate GMP For Clinical Manufacturing Needs
11/20/2023
Appropriate manufacturing and timely delivery of investigational products are essential for the successful execution of clinical trials. This article shares best practices working with CDMOs as well as phase-appropriate GMP of the clinical supply.
-
FDA Announces 1-Year “Stabilization” Period For DSCSA Compliance — Don't Mistake It For An Enforcement Delay
10/4/2023
On August 30 in a new guidance document, the FDA announced the establishment of a one-year stabilization period with regard to the enhanced security and unit-level electronic traceability requirements of the Drug Supply Chain Security Act (DSCSA) that go into effect on Nov. 27, 2023. The FDA makes it clear that this is not an opportunity to delay implementation; rather, it is an opportunity to refine, improve, and stabilize your systems and processes.
-
7 Improvements in Clinical Supply Chain Management Your CFO Will Love
10/2/2023
There is a great opportunity for clinical supply chain practitioners to learn from their commercial peers. By adapting and adopting the right commercial best practices, clinical supply chains become more effective, cost-efficient, and agile in delivering the right treatments to the right patients.